• OPEN AN ACCOUNT
Indian Indices
Sensex
76,957.27 -307.24
( -0.40%)
Global Indices
Nasdaq
53,569.16 -21.28
(-0.04%)
Dow Jones
7,731.77 -20.22
(-0.26%)
Hang Seng
66,147.06 -258.50
(-0.39%)
Nikkei 225
10,824.26 31.76
(0.29%)
Forex
USD-INR
95.48 0.22
(0.23%)
EUR-INR
111.24 0.16
(0.15%)
GBP-INR
129.74 0.04
(0.03%)
JPY-INR
0.60 0.00
(0.12%)

EQUITY - MARKET SCREENER

Vivimed Labs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532660
INE526G01021
-18.1148384
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VIVIMEDLAB
0
58.62
EPS(TTM)
Face Value()
Div & Yield %
0
2
0
 

KNR Constructions consolidated net profit declines 23.72% in the March 2026 quarter
May 30,2026
Net profit of KNR Constructions declined 23.72% to Rs 106.21 crore in the quarter ended March 2026 as against Rs 139.24 crore during the previous quarter ended March 2025. Sales declined 28.67% to Rs 695.59 crore in the quarter ended March 2026 as against Rs 975.21 crore during the previous quarter ended March 2025.

For the full year,net profit declined 56.37% to Rs 437.08 crore in the year ended March 2026 as against Rs 1001.87 crore during the previous year ended March 2025. Sales declined 43.24% to Rs 2698.01 crore in the year ended March 2026 as against Rs 4753.17 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales695.59975.21 -29 2698.014753.17 -43
OPM %24.3122.71 -26.3734.20 -
PBDT132.29206.21 -36 564.841733.17 -67
PBT118.34183.36 -35 505.381418.95 -64
NP106.21139.24 -24 437.081001.87 -56